Passage Bio, Inc. (NASDAQ:PASG) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Stuart Henderson - VP of Corporate Development and IR Edgar Cale - Interim CEO Simona King - CFO Mark Forman - Chief Medical Officer Conference Call Participants Brendan Smith - Cowen Neena Bitritto-Garg - Citi Alex Nackenoff - Raymond James Laura Chico - Wedbush Operator Good morning and welcome to the Passage Bio Second Quarter 2022 Financial and Operating Results Conference Call. [Operator Inst ...